Arno Therapeutics to Present at 17th Annual Rodman & Renshaw Conference

FLEMINGTON, N.J., Sept. 1, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of oncology therapeutics, today announced that Alexander Zukiwski, Chief Executive Officer & Chief Medical Officer of Arno Therapeutics is scheduled to present at the 17th Annual Rodman & Renshaw Global Investment conference being held September 8-10, 2015 in New York, NY.

Details of the presentations are as follows:

Conference: Rodman & Renshaw Global Investment Conference
Date: Thursday, September 10th, 2015
Time: 1:45 p.m. ET
Room: Astor Suite A, Second Floor of the St. Regis Hotel, NYC

Investors attending the conferences who would like to schedule a 1-on-1 meeting with Arno Therapeutics' management may do so by contacting their Rodman & Renshaw representatives, or Joseph Green at The Ruth Group at

About Arno Therapeutics

Arno Therapeutics is a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer and other life threatening diseases. Arno has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates. These compounds are in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors. For more information about the company, please visit

CONTACT: The Ruth Group Lee Roth (investors) (646) 536-7012 Kirsten Thomas (media) (646) 536-7014 Arno Therapeutics Lawrence Kenyon (862) 703-7171

Source:Arno Therapeutics Inc.